Personal Care Products

Natures Sunshine

Natures Sunshine released FY2026 Q1 earnings on May 7 After-Market EST, actual revenue USD 122.89 M (forecast USD 122.17 M), actual EPS USD 0.29 (forecast USD 0.225)

Natures Sunshine to Release FY2026 Q1 Earnings on May 7 After-Market EST, Forecast Revenue USD 122.74M, EPS USD 0.225

Natures Sunshine released FY2025 earnings on March 10 After-Market EST, actual revenue USD 480.14 M (forecast USD 477.82 M), actual EPS USD 1.06 (forecast USD 1.085)

Natures Sunshine released FY2025 Q4 earnings on March 10 After-Market (EST), actual revenue USD 123.81 M (forecast USD 121.5 M), actual EPS USD 0.2326 (forecast USD 0.185)

Natures Sunshine to release FY2025 Q4 earnings on March 10 After-Market EST, forecast revenue USD 121.62 M, EPS USD 0.19

Natures Sunshine released FY2025 Q3 earnings on November 6 After-Market (EST), actual revenue USD 128.34 M (forecast USD 120.3 M), actual EPS USD 0.3 (forecast USD 0.16)

Natures Sunshine released FY2025 9 Months Earnings on November 6 After-Market EST, Actual Revenue USD 356.34 M, Actual EPS USD 0.83

Natures Sunshine to release FY2025 Q3 earnings on November 6 After-Market EST, forecast revenue USD 120.3 M, EPS USD 0.16

Natures Sunshine released FY2025 Semi-Annual Earnings on July 31 After-Market EST, Actual Revenue: USD 228 M, Actual EPS: USD 0.54

Natures Sunshine released FY2025 Q2 earnings on July 31 After-Market EST, forecast revenue USD 112.25M, forecast EPS USD 0.16, actual revenue and EPS not reported

Natures Sunshine to release FY2025 Q2 earnings on July 31 After-Market EST, forecast revenue USD 113.1 M, EPS USD 0.165

Natures Sunshine released FY2025 Q1 earnings on May 6 After-Market EST, actual revenue USD 113.25 M (forecast USD 109.28 M), actual EPS USD 0.25 (forecast USD 0.165)

Natures Sunshine to release FY2025 Q1 earnings on May 6 After-Market EST, forecast revenue USD 109.39 M, EPS USD 0.165

NATR Releases 2024 Impact Report

Natures Sunshine released FY2024 Q4 earnings on March 11 After-Market (EST), actual revenue 118.21 M USD (forecast 109.3 M USD), actual EPS -0.0212 USD (forecast 0.2 USD)

Natures Sunshine released FY2024 Annual Earnings on March 11 After-Market (EST), actual revenue $454.36M (forecast $445.48M), actual EPS $0.4 (forecast $0.64)

Nature's Sunshine to Release FY2024 Q4 Earnings on March 11 After-Market EST, Forecast Revenue 109.46 M USD, EPS 0.2 USD

Natures Sunshine released FY2024 Q3 earnings on November 7 After-Market (EST), actual revenue $114.62M (forecast $108.94M), actual EPS $0.23 (forecast $0.14)

Natures Sunshine released FY2024 9 Months Earnings on November 7 After-Market (EST), with actual revenue of 336.159M USD and EPS of 0.42

Nature's Sunshine to Release FY2024 Q3 Earnings on November 7 After-Market EST, Forecast Revenue 108.94M USD, EPS 0.14 USD

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

NATR

The US market has shown a flat performance recently but has increased by 24% over the past year, with earnings expected to grow by 17% annually. Notable undiscovered gems include Esquire Financial Holdings, Nature's Sunshine Products, and Citizens, Inc., all showcasing strong fundamentals and growth potential. Esquire has a market cap of $863.72 million, Nature's Sunshine has surged earnings by 96.5%, and Citizens has shown 111.3% earnings growth, all trading below their estimated fair values, presenting investment opportunities.

Simplywall

Citizens

Esquire Financial

Discovering US Undiscovered Gems in May 2026

Nature’s Sunshine Products (NATR) reported strong Q1 earnings, with net sales of $122.9 million, a 9% year-over-year increase. The company highlighted record sales, expanding margins, and a debt-free balance sheet, while acknowledging geopolitical risks and potential normalization of growth. North America saw a 42% rise in digital revenue, while Asia Pacific, led by China, showed a 7% increase. Gross margin improved to 73.2%, and adjusted EBITDA rose 33%. However, cash flow from operations lagged behind earnings, and management cautioned about future growth sustainability in China and macroeconomic risks.

Tip Ranks

Nature’s Sunshine Earnings Call Highlights Profitable Growth

Earnings Watch

Natures Sunshine | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 122.89 M

Natures Sunshine | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 122.89 M

COST

Nature’s Sunshine Products Inc. (NASDAQ:NATR) is highlighted as a top small-cap consumer staples stock under $30. DA Davidson raised its price target for the company from $23 to $33 on March 12, maintaining a Buy rating, indicating a potential upside of over 39%.

Target

Costco Wholesale

Kroger

Will Nature’s Sunshine (NATR) capitalize on untapped opportunities?

Nature’s Sunshine Products (NATR) experienced notable insider activity on March 16, 2026, as Senior VP Jonathan David Lanoy sold 4,000 shares for $98,800. This move has drawn attention to executive trading decisions. Following a strong Q4 and full-year 2025 report, analysts raised price targets due to record sales and profitability. However, TipRanks’ AI Analyst rates NATR as Neutral, citing solid operational momentum but weak cash flow signals. The stock has a year-to-date price performance of 13.48% and a market cap of $428.8M.

Top Executive Makes Eye-Catching Move With Nature’s Sunshine Products Stock